TransMedics Group, Inc. (TMDX) Market Cap & Valuation Ratios
TransMedics Group, Inc. (TMDX) has a market cap of $2.5B and a price-to-sales ratio of 3.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMDXTransMedics Group, Inc.Follow TMDX — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| TMDX | 2.5 | — | 3.7 | 21.0 | 3.2% | +26% | 12% | 13% |
| IRTC | 4.0 | — | 4.9 | — | 1.0% | +26% | -3% | -5% |
| NEOG | 2.7 | — | 3.7 | 30.0 | 1.9% | -0.3% | -0.8% | -0.8% |
| UFPT | 2.3 | 31.9 | 3.8 | 20.7 | 2.7% | +7% | 15% | 14% |
| INSP | 2.1 | — | 1.9 | 24.3 | 5.7% | +4% | 6% | 7% |
| AXGN | 2.0 | — | 7.7 | — | 0.4% | +24% | -5% | -9% |
| ESTA | 1.9 | — | 8.5 | — | -2.2% | +39% | -8% | -9% |
| BFLY | 1.8 | — | 14.9 | — | -1.6% | +28% | -71% | -106% |
| ATEC | 1.7 | — | 2.7 | 77.8 | 0.1% | +19% | -6% | -11% |
| NVCR | 1.7 | — | 2.6 | — | -1.5% | +11% | -22% | -42% |
| CNMD | 1.5 | 26.6 | 1.7 | 14.0 | 9.1% | +3% | 8% | 4% |
| Median of these 10 | 29.2 | 3.7 | 24.3 | 0.7% | +15% | -4% | -7% |
; EV/Sales 3.7 vs. 3.7.
Growth vs. price
each dot a company · hover or tap for valuesTransMedics Group, Inc. — questions
- What is TransMedics Group, Inc.'s market cap?
- $2.5B.
- What is TransMedics Group, Inc.'s price-to-sales ratio?
- 3.7.
Every figure on this page comes from TransMedics Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.